Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
JAMA Oncology
|
June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations
Nikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study
Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
BJU International
|
February 5, 2025
Refining partial gland ablation for localised prostate cancer: the FALCON project
Lara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, et al.
Scientific Reports
|
October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
Lina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Radiology
|
December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
Vasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
The American Journal of Surgical Pathology
|
May 30, 2025
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer
Rajal B Shah, Gladell P Paner, Liang Cheng, et al.
European Urology
|
March 18, 2025
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach
Rajal B Shah, Gladell P Paner, Liang Cheng, et al.
Cancers
|
April 30, 2021
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
Hayley Pye, Saurabh Singh, Joseph M Norris, et al.
The Journal of Pathology
|
August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Histopathology
|
May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists
Mahra Nourbakshs, Liping Du, Andres M Acosta, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
JAMA Oncology
|
June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations
Nikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study
Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
BJU International
|
February 5, 2025
Refining partial gland ablation for localised prostate cancer: the FALCON project
Lara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, et al.
Scientific Reports
|
October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
Lina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Radiology
|
December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
Vasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
The American Journal of Surgical Pathology
|
May 30, 2025
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer
Rajal B Shah, Gladell P Paner, Liang Cheng, et al.
European Urology
|
March 18, 2025
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach
Rajal B Shah, Gladell P Paner, Liang Cheng, et al.
Cancers
|
April 30, 2021
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
Hayley Pye, Saurabh Singh, Joseph M Norris, et al.
The Journal of Pathology
|
August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Histopathology
|
May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists
Mahra Nourbakshs, Liping Du, Andres M Acosta, et al.
Page
of 10